Prudential Financial, Inc. 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-08 11:08 am Sale | 2026-03-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | PRUDENTIAL FINANCIAL INC PRU | 5,302,713 4.300% | -1,777,213 (-25.10%) | Filing |
| 2026-02-13 3:08 pm Sale | 2025-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | PRUDENTIAL FINANCIAL INC PRU | 7,079,926 5.700% | -4,874,144 (-40.77%) | Filing |
| 2025-05-15 5:41 pm Purchase | 2025-03-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | PRUDENTIAL FINANCIAL INC PRU | 11,954,070 10.100% | 2,069,933 (+20.94%) | Filing |
| 2024-02-14 3:58 pm Purchase | 2024-02-14 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | PRUDENTIAL FINANCIAL INC PRU | 9,884,137 10.470% | 233,326 (+2.42%) | Filing |
| 2023-11-09 2:54 pm Purchase | 2023-11-09 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | PRUDENTIAL FINANCIAL INC PRU | 9,650,811 10.250% | 9,650,811 (New Position) | Filing |